Abstract：Objective To investigate the clinical characteristics, inducing factors and treatment of Hailey-Hailey disease (HHD). Methods Clinical data of 24 patients with HHD admitted to department of dermatology in our hospital from January 1999 to December 2018 were retrospectively analyzed. Results Among the 24 patients, the male/female ratio was 3.8∶1. Patients age ranged from 31 to 70 years old, mean age was (49.54±9.02) years old. The onset age ranged from 13 to 47 years old, mean onset age was (31.04±9.49) years old. Groins and armpits were the most involved locations of rash. Hot and humid climate in summer was the most common triggers of HHD and followed by drinking,spicy foods and friction. The therapy of Compound Glycyrrhizin Injection, Minocycline Capsules, Glucosidorum Tripterygll Totorum combined with local symptomatic treatment was effective to HHD. Conclusion HHD is long-lasting, difficult to cure andprone to recurrence. Traditional treatment with systemic and topical medications can control symptoms, but it is difficult to prevent recurrence. Surgical treatment, laser treatment, and botulinum toxin injection play a certain role in preventing recurrence.
Engin B，Kutlubay Z，elik U，et al.Hailey-Hailey disease：A fold (intertriginous) dermatosis[J].Clin Dermatol，2015，33（4）：452-455.
[2]
Raiko L，Siljama ki E，Mahoney MG，et al.Hailey-Hailey Disease and Tight Junctions：Claudins 1 and 4 Are Regulated by ATP2C1 Gene Encoding Ca（2+）/Mn（2+）ATPase SPCA1 in Cultured Keratinocytes[J].Exp Dermatol，2012，21（8）：586-591.
Manca S，Magrelli A，Cialfi S，et al.Oxidative stress activation of miR-125b is part of the molecular switch for Hailey-Hailey disease manifestation[J].Exp Dermatol，2011，20（11）：932-937.
Kieffer J，Le Duff F，Montaudié H，et al.Treatment of Severe Hailey-Hailey Disease With Apremilast[J].JAMA Dermatol，2018，154（12）：1453-1456.
[10]
Kono M，Niizawa M，Takeichi T，et al.Hailey-Hailey disease due to ATP2C1 splice site mutation，successfully treated with minocycline hydrochloride[J].J Eur Acad Dermatol Venereol，2018，32（1）：e19-e20.
[11]
Farahnik B，Blattner CM，Mortazie MB，et al.Interventional treatments for Hailey-Hailey disease[J].J Am Acad Dermatol，2017，76（3）：551-558.
[12]
Ben Lagha I，Ashack K，Khachemoune A.Hailey-Hailey Disease：An Update Review with a Focus on Treatment Data[J].Am J Clin Dermatol，2019，21（1）：49-68.
[13]
Park AY，Lee HJ，Chung EH，et al.A Case Report of Hailey-Hailey Disease Treated with Alitretinoin[J].Ann Dermatol，2019，31（Suppl）：S1-S2.
Leung N，Cardones AR，Larrier N.Long-term improvement of recalcitrant Hailey-Hailey disease with electron beam radiation therapy：Case report and review[J].Pract Radiat Oncol，2018，8（5）：e259-e261.
[18]
Lapiere JC，Hirsh A，Gordon KB，et al.Botulinum toxin A for the treatment of axillary Hailey-Hailey disease[J].Dematol Surg，2000，26（4）：371-374.
[19]
Kothapalli A，Caccetta T.Botulinum toxin type A for the first-line treatment of Hailey-Hailey disease[J].Australas J Dermatol，2019，60（1）：73-74.
[20]
Dousset L，Pham-Ledard A，Doutre MS，et al.Treatment of Hailey-Hailey disease with botulinic toxin：A retrospective study of 8 cases[J].Ann Dermatol Venereol，2017，144（10）：599-606.
[21]
Charlton OA，Stewart TJ，Rosen RH.Treatment of Hailey-Hailey disease with botulinum toxin[J].Australas J Dermatol，2018，59（3）：229-231.
京公网安备 11010502046607号